CHANELLE PHARMACEUTICALS MANUFACTURING LTD 156455 (Q233918): Difference between revisions

@@ Property / Irish Koesio Identifier @@
@@ Property / Irish Koesio Identifier: 514 / rank @@
+Normal rank
@@ Property / instance of @@
+Kohesio project
@@ Property / instance of: Kohesio project / rank @@
+Normal rank
@@ Property / financed by @@
+European Union
@@ Property / financed by: European Union / rank @@
+Normal rank
@@ Property / financed by @@
+Directorate-General for Regional and Urban Policy
+Normal rank
@@ Property / country @@
+Ireland
@@ Property / country: Ireland / rank @@
+Normal rank
@@ Property / EU contribution @@
+,556.475 EuroAmount 50,556.475 Euro
Unit Euro
-Amount
+,556.475 Euro
-Unit
+Euro
@@ Property / EU contribution: 50,556.475 Euro / rank @@
+Normal rank
@@ Property / budget @@
+,112.95 EuroAmount 101,112.95 Euro
Unit Euro
-Amount
+,112.95 Euro
-Unit
+Euro
@@ Property / budget: 101,112.95 Euro / rank @@
+Normal rank
@@ Property / coordinate location @@
+°16'27.88"N, 9°2'56.62"WLatitude 53.2744122
Longitude -9.0490632
Precision 1.0E-5
Globe http://www.wikidata.org/entity/Q2
-Latitude
+.2744122
-Longitude
+-9.0490632
-Precision
+.0E-5
-Globe
+http://www.wikidata.org/entity/Q2
@@ Property / coordinate location: 53°16'27.88"N, 9°2'56.62"W / rank @@
+Normal rank
@@ Property / start time @@
+April 2014Timestamp +2014-04-04T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2014-04-04T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / start time: 4 April 2014 / rank @@
+Normal rank
@@ Property / end time @@
+September 2017Timestamp +2017-09-15T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2017-09-15T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / end time: 15 September 2017 / rank @@
+Normal rank
@@ Property / co-financing rate @@
+.0 percentAmount 50.0 percent
Unit percent
-Amount
+.0 percent
-Unit
+percent
@@ Property / co-financing rate: 50.0 percent / rank @@
+Normal rank
@@ Property / beneficiary name (string) @@
+CHANELLE PHARMACEUTICALS MANUFACTURING LTD
+Normal rank
@@ Property / summary @@
+Develop a range of medical products (English)
@@ Property / summary: Develop a range of medical products (English) / rank @@
+Normal rank